Healthcare Industry News:  ezetimibe/simvastatin 

Biopharmaceuticals FDA

 News Release - October 5, 2006

FDA Approves New Label for VYTORIN(R) (ezetimibe/simvastatin)





Source: Merck/Schering-Plough Pharmaceuticals

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.